Publications by authors named "Harold Shlevin"

Claim this Profile
M
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis.
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Harold Shlevin

Aliment Pharmacol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
Brendan D Curti, Yoshinobu Koguchi, Rom S Leidner, Annah S Rolig, Elizabeth R Sturgill, Harold Shlevin

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity.
Elizabeth R Sturgill, Annah S Rolig, Stefanie N Linch, Courtney Mick, Melissa J Kasiewicz, Harold Shlevin

Oncoimmunology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.
Naga Chalasani, Manal F Abdelmalek, Guadalupe Garcia-Tsao, Raj Vuppalanchi, Naim Alkhouri, Harold Shlevin

Gastroenterology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.
Hani Shamseddeen, Eduardo Vilar-Gomez, Naga Chalasani, Robert P Myers, G Mani Subramanian, Harold H Shlevin

Drug Saf· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis.
Simon Ritchie, Danielle Neal, Harold Shlevin, Adam Allgood, Peter Traber

J Am Acad Dermatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis